Enveric Biosciences

(NASDAQ) ENVB

Current Price$2.10

Market Cap$4.19M

Since IPO (2020)-100%

5 Year-100%

1 Year-86%

1 Month+18%

Enveric Biosciences Financials at a Glance

Market Cap

$4.19M

Revenue (TTM)

$0.00

Net Income (TTM)

$8.22M

EPS (TTM)

$-27.35

P/E Ratio

-0.08

Dividend

$0.00

Beta (Volatility)

1.43 (Average)

Dividend

$0.00

Beta (Volatility)

1.43 (Average)

Price

$2.10

Volume

917,267.518

Open

$1.99

Price

$2.10

Volume

917,267.518

Open

$1.99

Previous Close

$2.11

Daily Range

$1.86 - $2.14

52-Week Range

$1.71 - $17.64

Dividend

$0.00

Beta (Volatility)

1.43 (Average)

Price

$2.10

Volume

917,267.518

Open

$1.99

Previous Close

$2.11

Daily Range

$1.86 - $2.14

52-Week Range

$1.71 - $17.64

ENVB News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Enveric Biosciences

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Joseph Tucker, PhD

Website

www.enveric.com

Headquarters

Naples, FL 34103, US

ENVB Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-183%

Return on Capital

-2%

Return on Assets

-1%

Earnings Yield

-12.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.19M

Shares Outstanding

1.99M

Volume

917.27K

Avg. Volume

3.87M

Financials (TTM)

Gross Profit

$200.86K

Operating Income

$8.77M

EBITDA

$8.57M

Operating Cash Flow

$8.14M

Capital Expenditure

$0.00

Free Cash Flow

$8.14M

Cash & ST Invst.

$4.68M

Total Debt

$0.00

Enveric Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$37.24K

+54.0%

Gross Margin

0.00%

N/A

Market Cap

$4.19M

N/A

Market Cap/Employee

$837.90K

N/A

Employees

N/A

Net Income

$1.63M

+25.2%

EBITDA

$1.60M

+24.1%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$4.91M

+14.3%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.49%

N/A

Return on Invested Capital

-1.62%

N/A

Free Cash Flow

$2.26M

+5.6%

Operating Cash Flow

$2.26M

+5.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SLRXSalarius Pharmaceuticals, Inc.

SLRXSalarius Pharmaceuticals, Inc.$0.84+29.23%

INDPIndaptus Therapeutics, Inc.

INDPIndaptus Therapeutics, Inc.$1.33-12.50%

ZVSAZyVersa Therapeutics, Inc.

ZVSAZyVersa Therapeutics, Inc.$0.18-5.61%

HEPAHepion Pharmaceuticals, Inc.

HEPAHepion Pharmaceuticals, Inc.$0.07-22.58%

SCNIScinai Immunotherapeutics Ltd.

SCNIScinai Immunotherapeutics Ltd.$0.51-9.27%

ONCOOnconetix, Inc.

ONCOOnconetix, Inc.$0.12-61.56%

SPRCSciSparc Ltd.

SPRCSciSparc Ltd.$4.55+3.88%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$72.93-0.02%

NOKNokia

NOKNokia$13.67-0.01%

POETPoet Technologies

POETPoet Technologies$13.07-0.08%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.79-0.03%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$44.37+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$12.06-0.02%

TET1 Energy Inc.

TET1 Energy Inc.$6.88-0.02%

Questions About ENVB

What is the current price of Enveric Biosciences?

Enveric Biosciences is trading at $2.11 per share.

What is the 52-week range for Enveric Biosciences?

Over the past 52 weeks, Enveric Biosciences has traded between $1.71 and $17.64.

How much debt does Enveric Biosciences have?

As of the most recent reporting period, Enveric Biosciences reported total debt of N/A.

How much cash does Enveric Biosciences have on hand?

Enveric Biosciences reported $4.91M in cash and cash equivalents in its most recent financial results.

What is Enveric Biosciences’s dividend yield?

Enveric Biosciences does not currently have a dividend yield.

Enveric Biosciences

Enveric Biosciences Financials at a Glance

ENVB News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Enveric Biosciences

ENVB Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Enveric Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ENVB

What is the current price of Enveric Biosciences?

What is the 52-week range for Enveric Biosciences?

How much debt does Enveric Biosciences have?

How much cash does Enveric Biosciences have on hand?

What is Enveric Biosciences’s dividend yield?

Premium Investing Services